Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders

The dopamine D3 receptor has been the subject of a tremendous amount of research since its discovery in 1990. A previous review of this subject [3] described the advances in molecular biology and neuroanatomical localization of the D3 receptor, with a special emphasis on schizophrenia. In the curren...

Full description

Saved in:
Bibliographic Details
Published inCurrent pharmaceutical design Vol. 9; no. 8; pp. 643 - 671
Main Authors Luedtke, Robert, Mach, Robert
Format Journal Article
LanguageEnglish
Published United Arab Emirates Bentham Science Publishers Ltd 01.01.2003
Subjects
Online AccessGet full text
ISSN1381-6128
1873-4286
DOI10.2174/1381612033391199

Cover

Abstract The dopamine D3 receptor has been the subject of a tremendous amount of research since its discovery in 1990. A previous review of this subject [3] described the advances in molecular biology and neuroanatomical localization of the D3 receptor, with a special emphasis on schizophrenia. In the current review, we attempt to describe recent advances in the biochemistry and pharmacology of the D3 receptor from the molecular to the behavioral level. Evidence linking an alteration in D3 receptor function as playing an important role in the etiology of a variety of CNS disorders, including schizophrenia, Parkinsons Disease, and substance abuse is also provided. Also discussed are the recent developments in attempting to map the ligand-binding domains of the D2 and D3 receptors. A. survey of the literature, including a description of the medicinal chemistry approaches toward developing D3-selective ligands, is also presented in this review.
AbstractList The dopamine D3 receptor has been the subject of a tremendous amount of research since its discovery in 1990. A previous review of this subject [3] described the advances in molecular biology and neuroanatomical localization of the D3 receptor, with a special emphasis on schizophrenia. In the current review, we attempt to describe recent advances in the biochemistry and pharmacology of the D3 receptor from the molecular to the behavioral level. Evidence linking an alteration in D3 receptor function as playing an important role in the etiology of a variety of CNS disorders, including schizophrenia, Parkinsons Disease, and substance abuse is also provided. Also discussed are the recent developments in attempting to map the ligand-binding domains of the D2 and D3 receptors. A. survey of the literature, including a description of the medicinal chemistry approaches toward developing D3-selective ligands, is also presented in this review.
The dopamine D3 receptor has been the subject of a tremendous amount of research since its discovery in 1990. A previous review of this subject [3] described the advances in molecular biology and neuroanatomical localization of the D3 receptor, with a special emphasis on schizophrenia. In the current review, we attempt to describe recent advances in the biochemistry and pharmacology of the D3 receptor from the molecular to the behavioral level. Evidence linking an alteration in D3 receptor function as playing an important role in the etiology of a variety of CNS disorders, including schizophrenia, Parkinson's Disease, and substance abuse is also provided. Also discussed are the recent developments in attempting to map the ligand-binding domains of the D2 and D3 receptors. A. survey of the literature, including a description of the medicinal chemistry approaches toward developing D3-selective ligands, is also presented in this review.
The dopamine D3 receptor has been the subject of a tremendous amount of research since its discovery in 1990. A previous review of this subject [3] described the advances in molecular biology and neuroanatomical localization of the D3 receptor, with a special emphasis on schizophrenia. In the current review, we attempt to describe recent advances in the biochemistry and pharmacology of the D3 receptor from the molecular to the behavioral level. Evidence linking an alteration in D3 receptor function as playing an important role in the etiology of a variety of CNS disorders, including schizophrenia, Parkinson's Disease, and substance abuse is also provided. Also discussed are the recent developments in attempting to map the ligand-binding domains of the D2 and D3 receptors. A. survey of the literature, including a description of the medicinal chemistry approaches toward developing D3-selective ligands, is also presented in this review.The dopamine D3 receptor has been the subject of a tremendous amount of research since its discovery in 1990. A previous review of this subject [3] described the advances in molecular biology and neuroanatomical localization of the D3 receptor, with a special emphasis on schizophrenia. In the current review, we attempt to describe recent advances in the biochemistry and pharmacology of the D3 receptor from the molecular to the behavioral level. Evidence linking an alteration in D3 receptor function as playing an important role in the etiology of a variety of CNS disorders, including schizophrenia, Parkinson's Disease, and substance abuse is also provided. Also discussed are the recent developments in attempting to map the ligand-binding domains of the D2 and D3 receptors. A. survey of the literature, including a description of the medicinal chemistry approaches toward developing D3-selective ligands, is also presented in this review.
Author Robert Mach
Robert Luedtke
Author_xml – sequence: 1
  givenname: Robert
  surname: Luedtke
  fullname: Luedtke, Robert
– sequence: 2
  givenname: Robert
  surname: Mach
  fullname: Mach, Robert
BackLink https://www.ncbi.nlm.nih.gov/pubmed/12570797$$D View this record in MEDLINE/PubMed
BookMark eNp9kc2PFCEQxTtmjfuhd0-GePDWCg3TDcfNjl_JRDdmPROaru5hpQGB3sle9R-XyexqMgdPVXn1exTwzqsT5x1U1UuC3zakY-8I5aQlDaaUCkKEeFKdEd7RmjW8PSl9Gddlzk-r85RuMSaNIOxZdUqaVYc70Z1Vv6-jnyKkhIxDa7gD64NxE1pTtPZBzcYB-gYaQvYRbcyk3JCQSujaZ3DZKItuthBVgCUbjS6nIiY0FvYLLNFbPxldmOI6CCHd661RORZ4bZKPA8T0vHo6KpvgxUO9qL5_eH9z9anefP34-epyU_eMrXLNcUM4YXjQ_dC2nNNR4HZclYevhkEoonivGMNcE6wELUWJngEw0YxqZFTRi-rN4dwQ_c8FUpazSRqsVQ78kmRHMSEdJwV8fQTe-iW6cjfZkBVpKGZ76NUDtPQzDDJEM6t4Lx__tgD4AOjoU4ow_kOw3Mcnj-MrlvbIok1W2XiXozL2f8ZfB2NfAtiqOWkDTsPfjducg9ztdrKEAD9UAgs6S-1n6QO4JdrSu32iMmyDLClGkCqWSC1Ik5J73MjlnbfLDFLs5QUklymoCWTLKP0DJMDQAQ
CitedBy_id crossref_primary_10_1371_journal_pone_0049483
crossref_primary_10_3390_molecules23112737
crossref_primary_10_1016_j_bmcl_2009_01_067
crossref_primary_10_1016_j_bmc_2013_03_059
crossref_primary_10_1051_medsci_2005214434
crossref_primary_10_1016_j_nucmedbio_2013_02_011
crossref_primary_10_1021_jm0704200
crossref_primary_10_1021_jm030836n
crossref_primary_10_1111_j_1471_4159_2007_04660_x
crossref_primary_10_1016_j_neulet_2018_03_006
crossref_primary_10_1016_j_bmc_2011_04_021
crossref_primary_10_1016_j_bmcl_2004_09_047
crossref_primary_10_1002_syn_20725
crossref_primary_10_1021_jm049031l
crossref_primary_10_1021_cn300142q
crossref_primary_10_1002_syn_21691
crossref_primary_10_1016_j_bmcl_2003_09_083
crossref_primary_10_1021_ci100290f
crossref_primary_10_1016_j_cpet_2010_02_002
crossref_primary_10_1016_j_bmc_2004_06_019
crossref_primary_10_1016_j_bmc_2010_05_052
crossref_primary_10_1021_jm701524h
crossref_primary_10_1021_jm050729o
crossref_primary_10_1021_acs_jmedchem_7b01248
crossref_primary_10_1021_jm040190e
crossref_primary_10_1021_jm049465g
crossref_primary_10_1016_j_bmcl_2015_12_068
crossref_primary_10_1097_FBP_0b013e32831c3b2b
crossref_primary_10_1016_j_bmcl_2006_10_076
crossref_primary_10_1016_j_tips_2010_12_003
crossref_primary_10_1016_j_bmc_2007_08_034
crossref_primary_10_1016_j_bmc_2004_09_054
crossref_primary_10_1016_j_neuroimage_2013_01_007
crossref_primary_10_1002_syn_20652
crossref_primary_10_1039_c3md00098b
crossref_primary_10_1016_j_nucmedbio_2011_01_002
crossref_primary_10_1002_syn_20891
crossref_primary_10_1002_cmdc_200700067
crossref_primary_10_3389_fcvm_2021_732282
crossref_primary_10_1080_13880200490505654
crossref_primary_10_1016_j_neuropharm_2012_08_011
crossref_primary_10_1021_jm070860r
crossref_primary_10_1016_j_bmc_2013_03_074
crossref_primary_10_1016_j_bmcl_2012_07_003
crossref_primary_10_1176_appi_psy_49_4_347
crossref_primary_10_1007_s00044_024_03291_3
crossref_primary_10_1016_j_bmcl_2005_01_037
crossref_primary_10_1016_j_bmc_2003_10_011
crossref_primary_10_1016_j_bmc_2005_09_008
crossref_primary_10_1016_j_pharmthera_2006_04_007
crossref_primary_10_1107_S160053681005155X
crossref_primary_10_1021_cr300113a
crossref_primary_10_1176_appi_psy_49_3_258
crossref_primary_10_1002_syn_20748
crossref_primary_10_1002_ardp_200400997
crossref_primary_10_1007_s11011_015_9753_2
crossref_primary_10_1124_jpet_112_202911
crossref_primary_10_1002_jlcr_3558
crossref_primary_10_1021_jm101323b
crossref_primary_10_1016_j_bmcl_2010_07_096
crossref_primary_10_1016_j_bmc_2009_04_031
crossref_primary_10_1186_s40658_018_0219_6
crossref_primary_10_3389_fnins_2016_00451
crossref_primary_10_1002_cbic_200300784
crossref_primary_10_1080_14756360701830023
crossref_primary_10_1016_S1359_6446_05_03491_4
crossref_primary_10_1211_jpp_58_2_0008
crossref_primary_10_1021_cr050263h
crossref_primary_10_1016_j_neuropharm_2010_09_011
crossref_primary_10_1016_j_bmc_2008_11_044
ContentType Journal Article
Copyright Copyright © 2003 Bentham Science Publishers
Copyright_xml – notice: Copyright © 2003 Bentham Science Publishers
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7QO
7T7
7TK
7U7
7U9
7X7
7XB
88E
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
C1K
CCPQU
FR3
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.2174/1381612033391199
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Toxicology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
Toxicology Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
Technology Research Database
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-4286
EndPage 671
ExternalDocumentID 1007537301
12570797
10_2174_1381612033391199
http_www_eurekaselect_com_openurl_content_php_genre_article_issn_13816128_volume_9_issue_8_spage_643
Genre Journal Article
Review
GroupedDBID ---
.5.
0R~
29F
36B
3V.
4.4
53G
5GY
69Q
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AAEGP
ABEEF
ABJNI
ABUWG
ABVDF
ACGFO
ACGFS
ACITR
ACIWK
ACPRK
ADBBV
AENEX
AFKRA
AFRAH
AFUQM
AGJNZ
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ANTIV
BENPR
BPHCQ
BVXVI
C1A
CCPQU
CS3
DU5
EBS
EJD
F5P
FYUFA
GH2
HMCUK
HZ~
IPNFZ
KCGFV
KFI
M1P
O9-
P2P
PQQKQ
PROAC
PSQYO
Q2X
RIG
UKHRP
AAYXX
AFHZU
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PUEGO
ACZAY
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QO
7T7
7TK
7U7
7U9
7XB
8FD
8FK
C1K
FR3
H94
K9.
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-b445t-80218140dcbd66883f906f59115dd9a1a8ba4408c10a938c1a9b4ee492faf43a3
IEDL.DBID 7X7
ISSN 1381-6128
IngestDate Fri Sep 05 13:36:05 EDT 2025
Sat Aug 23 13:35:41 EDT 2025
Thu Jan 02 23:03:59 EST 2025
Wed Oct 01 02:49:36 EDT 2025
Thu Apr 24 23:05:32 EDT 2025
Tue Aug 27 15:42:25 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b445t-80218140dcbd66883f906f59115dd9a1a8ba4408c10a938c1a9b4ee492faf43a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
PMID 12570797
PQID 215123041
PQPubID 42716
PageCount 29
ParticipantIDs proquest_miscellaneous_73011781
proquest_journals_215123041
pubmed_primary_12570797
crossref_primary_10_2174_1381612033391199
crossref_citationtrail_10_2174_1381612033391199
benthamscience_primary_http_www_eurekaselect_com_openurl_content_php_genre_article_issn_13816128_volume_9_issue_8_spage_643
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2003-01-01
PublicationDateYYYYMMDD 2003-01-01
PublicationDate_xml – month: 01
  year: 2003
  text: 2003-01-01
  day: 01
PublicationDecade 2000
PublicationPlace United Arab Emirates
PublicationPlace_xml – name: United Arab Emirates
– name: Schiphol
PublicationTitle Current pharmaceutical design
PublicationTitleAlternate CPD
PublicationYear 2003
Publisher Bentham Science Publishers Ltd
Publisher_xml – name: Bentham Science Publishers Ltd
SSID ssj0012914
Score 2.025405
SecondaryResourceType review_article
Snippet The dopamine D3 receptor has been the subject of a tremendous amount of research since its discovery in 1990. A previous review of this subject [3] described...
SourceID proquest
pubmed
crossref
benthamscience
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 643
SubjectTerms Amino Acid Sequence
Animals
Benzamides - chemistry
Benzamides - pharmacology
Benzamides - therapeutic use
Binding Sites
Drug Design
Humans
Ligands
Molecular Sequence Data
Parkinson Disease - drug therapy
Parkinson Disease - metabolism
Receptors, Dopamine D2 - drug effects
Receptors, Dopamine D2 - metabolism
Receptors, Dopamine D2 - physiology
Receptors, Dopamine D3
Schizophrenia - drug therapy
Schizophrenia - metabolism
Second Messenger Systems - physiology
Substance-Related Disorders - drug therapy
Substance-Related Disorders - metabolism
Tetrahydronaphthalenes - chemistry
Tetrahydronaphthalenes - pharmacology
Tetrahydronaphthalenes - therapeutic use
Title Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders
URI http://www.eurekaselect.com/openurl/content.php?genre=article&issn=13816128&volume=9&issue=8&spage=643
https://www.ncbi.nlm.nih.gov/pubmed/12570797
https://www.proquest.com/docview/215123041
https://www.proquest.com/docview/73011781
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Health & Medical Collection (ProQuest)
  customDbUrl:
  eissn: 1873-4286
  dateEnd: 20081231
  omitProxy: true
  ssIdentifier: ssj0012914
  issn: 1381-6128
  databaseCode: 7X7
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1873-4286
  dateEnd: 20081231
  omitProxy: true
  ssIdentifier: ssj0012914
  issn: 1381-6128
  databaseCode: BENPR
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagvXAA8WYpFB9QJaRGm6zzsE-osK0qBFWEWmlvIzt22gqaTZvtoeLIH2fGcbIUqZwiOc5D8cw338TzYOx9bnOrnTORNCKOUuGqSNWzOhJVFTubOC0yykb-dpQfnqRfFtkixOZ0IaxywEQP1HZZ0T_yqTdN6HsnH9vLiJpG0eZq6KBxn20myFRIqIvF6G-hJUv6nrYyQQ9pJvtdSuLgUxrDoVgIgdpOhV8fGgT5M30RDM9tM3UH9_Q26OAxexTII9_rV_sJu-eap2yn7KtP3-zy43UyVbfLd3i5rkt984z9LikWC5GNnzd8PiZL8bngc3SdL5BvcmSRrkU3nH89P6UkYK47Xi5XFFKED_7r_nyPcrI6jpyX-wIfAUM5XtUPjHHUOHmo8dk9ZycH-8efD6PQgyEyaZqt0IARB0hjWxmb51KKWsV5neFHy6xVOtHSaGpaXSWxVgIPWpnUuVTNal2nQosXbKNZNu4V46j9uaozPIekx8oKpcfqwuTWxFWRqdmE_bq9BtD2BTd86hGgZAC-vfuhO98hCFA6ILQYA4rrp67E7VkLXvEgKB4QlEJYbgk95IMCL9UgwcM2IC2bsOmw4FCF8ujUpeMnoJtEMgP_ysyEfRivGN707rlbgwxBAIkORpGesHfjWdRu2rLRjVted-Dxt5A442UveOsnUfvBQhWv_3vnLfbARx_6f0Zv2Mbq6tq9RRa1MtteV7bZ5qf9o_L7HxkEI0o
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKOcABxJulQH2ASkiNNonzcA4IVSzVlm6rPWylvQ127NAKmg1kK7TiyO_hPzLjPJYilVtPkRzHtjTveGY-xl4lJjHKWu1JLXwvEjb3siIsPJHnvjWBVSKmauSj42R8En2cx_MN9rurhaG0yk4nOkVtFjn9Ix8604Sxd_Cu-uYRaBRdrnYIGg1XHNrVD4zY6rcHIyTv6zDc_zB7P_ZaUAFPR1G8RI1MRi3yTa5NkkgpisxPihhlPjYmU4GSWhEKcx74KhP4UJmOrI2ysFBFJJTAdW-wmxEehVr1p_M-vkPLGTQYujLAiCyUza0o-fxDGsMhXwiBO1Gj2TsajcqpOm8N3WWzeIWv62ze_j12t3VW-V7DXffZhi0fsJ1p0-16tctn6-Ktepfv8Om6D_bqIfs1pdwv1KT8rOSjvjiLjwQfYah-jv4tR6_VVhj288nZZyo65qrm08WSUphw47_W53tUA1Zz9LG5ayjS6myOXzUDfd42Tu56itaP2Mm1kOcx2ywXpX3KOGqbJCtifIdOlpE5cqtRqU6M9vM0zsIB-3mZBlA1DT5cqRMgJwKe3n5RtUMkAuRGaCHNgOoICAW5Oq3ACTq0gg6kuqElt4TGxEAGTopAgjMTgG7ggA07gkPetmMnVJCvgGEZ8Qz8yzMD9qb_ojvp1XO3Oh6CVinV0IvQgG33b1Gb0BWRKu3iogan71OJM540jLfeieAO0yx99t-Vt9mt8exoApOD48MtdttlPrr_Vc_Z5vL7hX2BHtxSv3Ryw9mn6xbUP-HqXeQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Progress+in+Developing+D3+Dopamine+Receptor+Ligands+as+Potential+Therapeutic+Agents+for+Neurological+and+Neuropsychiatric+Disorders&rft.jtitle=Current+pharmaceutical+design&rft.au=Luedtke%2C+R+R&rft.au=Mach%2C+R+H&rft.date=2003-01-01&rft.pub=Bentham+Science+Publishers+Ltd&rft.issn=1381-6128&rft.eissn=1873-4286&rft.volume=9&rft.issue=8&rft.spage=643&rft_id=info:doi/10.2174%2F1381612033391199&rft.externalDocID=1007537301
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1381-6128&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1381-6128&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1381-6128&client=summon